These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10534696)

  • 1. M1a/M1b esophageal carcinoma: clinical relevance.
    Christie NA; Rice TW; DeCamp MM; Goldblum JR; Adelstein DJ; Zuccaro G; Rybicki LA; Blackstone EH
    J Thorac Cardiovasc Surg; 1999 Nov; 118(5):900-7. PubMed ID: 10534696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.
    Lee SS; Kim SB; Park SI; Kim YH; Ryu JS; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
    Jpn J Clin Oncol; 2007 Nov; 37(11):829-35. PubMed ID: 17951334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis after surgical resection of M1a/M1b esophageal squamous cell carcinoma.
    Shim YM; Choi YS; Kim K
    J Korean Med Sci; 2005 Apr; 20(2):229-31. PubMed ID: 15831992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors.
    Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H
    Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after chemoradiotherapy.
    Chao YK; Wu YC; Liu YH; Tseng CK; Chang HK; Hsieh MJ; Chu Y; Liu HP
    J Surg Oncol; 2010 Aug; 102(2):158-62. PubMed ID: 20648587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
    Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs.
    Feng F; Cai W; Wang G; Chen W; Yang H; Sun M; Zhou L
    BMC Gastroenterol; 2020 Aug; 20(1):289. PubMed ID: 32854631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non-Small Cell Lung Cancer.
    Shin J; Keam B; Kim M; Park YS; Kim TM; Kim DW; Kim YW; Heo DS
    J Thorac Oncol; 2017 Mar; 12(3):520-528. PubMed ID: 27867003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The place of surgery in metastatic non-small cell lung cancer].
    Le Pimpec Barthes F; Mordant P; Pricopi C; Foucault C; Dujon A; Riquet M
    Rev Mal Respir; 2012 Mar; 29(3):376-83. PubMed ID: 22440301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downstaging of esophageal cancer after preoperative radiation and chemotherapy.
    Vogel SB; Mendenhall WM; Sombeck MD; Marsh R; Woodward ER
    Ann Surg; 1995 Jun; 221(6):685-93; discussion 693-5. PubMed ID: 7794073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
    Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
    Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy followed by surgery in patients with carcinoma of the distal esophagus and celiac lymph node involvement.
    Boonstra JJ; Koppert LB; Wijnhoven BP; Tilanus HW; Van Dekken H; Tran TC; Van der Gaast A
    J Surg Oncol; 2009 Oct; 100(5):407-13. PubMed ID: 19653239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal adenocarcinoma patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases: A propensity score matching analysis.
    Li CL; Tang DR; Ji J; Zang B; Chen C; Zhao JQ
    World J Clin Cases; 2020 Aug; 8(15):3230-3239. PubMed ID: 32874977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of M1a and M1b category in metastatic colorectal cancer.
    Kennecke H; Yu J; Gill S; Cheung WY; Blanke CD; Speers C; Woods R
    Oncologist; 2014 Jul; 19(7):720-6. PubMed ID: 24899642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer.
    Hammoud ZT; Kesler KA; Ferguson MK; Battafarrano RJ; Bhogaraju A; Hanna N; Govindan R; Mauer AA; Yu M; Einhorn LH
    Dis Esophagus; 2006; 19(2):69-72. PubMed ID: 16643172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characteristics, diagnosis, treatment, and outcomes of primary gastric adenosquamous carcinoma.
    Chen H; Shen C; Yin R; Yin Y; Chen J; Han L; Zhang B; Chen Z; Chen J
    World J Surg Oncol; 2015 Apr; 13():136. PubMed ID: 25889482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.
    Gockel I; Kneist W; Junginger T
    World J Surg; 2006 Feb; 30(2):183-90. PubMed ID: 16425075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.